AOM Infusion (“AOM”), a leading provider of specialty infusion and pharmacy services for chronic and complex conditions, has been selected by Kedrion Biopharma as a limited distribution network ...

Organizations are scaling efforts nationwide to support food-insecure Americans. Across the country, food banks and community-based organizations have scaled up efforts with a call to action to help ...

You may have heard of an influencing technique called "rational persuasion." In fact, you have probably used it yourself. This technique involves giving a series of reasons to persuade another person ...

After a whirlwind weekend of shopping Black Friday and Cyber Monday deals, this Tuesday, Dec. 2, is a chance to give back to the community. The Tuesday after Thanksgiving is globally recognized as ...

An AJMC Stakeholder Interchange in Atlanta, Georgia addressed the need for collaboration to bring bispecific antibodies to the outpatient setting in multiple myeloma. Participants discussed the use of ...

Lend your time, money, or resources to make a difference this season. Giving Tuesday is an annual holiday that encourages showing generosity to community members in need. Use the holiday as an ...

As fundraisers head into giving season, they’re often thinking about tactics to sway donors, but not necessarily the science underlying a donor’s decision-making. With GivingTuesday serving as the ...

Some lessons we teach our kids come naturally, such as saying "please" or "thank you." Others take a little more creativity and patience. Teaching them to give back definitely falls into that second ...

While traditional gifts are great, show someone you care with a donation to a charity, non-profit and more. These heartfelt gifts give back to the community in 2025. While you don’t need to be a ...

The combined company will expand access to home and ambulatory infusion therapy across the U.S. with a focus on patient-centered care and clinical excellence. CHICAGO, November 20, 2025--(BUSINESS ...

During a live event, Thomas G. Martin, MD, discussed the importance of controlling disease and avoiding barriers to access so patients with multiple myeloma can receive CAR T-cell therapy.